Metformin: review of epidemiology and mechanisms of action in pancreatic cancer.
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer.
复制标题
代谢:流行病学和胰腺癌作用机制的回顾。
DOI:
10.1007/s10555-021-09977-z
复制
发表时间:
2021-09
期刊:
影响因子:
--
通讯作者:
Rozengurt E
中科院分区:
文献类型:
--
作者:
Eibl G;Rozengurt E
Pancreatic ductal adenocarcinoma continues to be a lethal disease, for which efficient treatment options are very limited. Increasing efforts have been taken to understand how to prevent or intercept this disease at an early stage. There is convincing evidence from epidemiologic and preclinical studies that the anti-diabetic drug metformin possesses beneficial effects in pancreatic cancer, including reducing the risk of developing the disease and improving survival in patients with early stage disease. This review will summarize the current literature about the epidemiological data on metformin and pancreatic cancer as well as describe the preclinical evidence illustrating the anti-cancer effects of metformin in pancreatic cancer. Underlying mechanisms and targets of metformin will also be discussed. These include direct effects on transformed pancreatic epithelial cells and indirect, systemic effects on extra-pancreatic tissues.
登录
查看更多内容
影响因子:
7.7
作者:
Cifarelli V;Lashinger LM;Devlin KL;Dunlap SM;Huang J;Kaaks R;Pollak MN;Hursting SD
通讯作者:
Hursting SD
影响因子:
7.7
作者:
Andersen DK;Korc M;Petersen GM;Eibl G;Li D;Rickels MR;Chari ST;Abbruzzese JL
通讯作者:
Abbruzzese JL
影响因子:
37.3
作者:
Chen K;Qian W;Jiang Z;Cheng L;Li J;Sun L;Zhou C;Gao L;Lei M;Yan B;Cao J;Duan W;Ma Q
通讯作者:
Ma Q
DOI:
10.1158/1940-6207.capr-13-0065
发表时间:
2013-10
期刊:
Cancer prevention research (Philadelphia, Pa.)
影响因子:
--
作者:
Dawson DW;Hertzer K;Moro A;Donald G;Chang HH;Go VL;Pandol SJ;Lugea A;Gukovskaya AS;Li G;Hines OJ;Rozengurt E;Eibl G
通讯作者:
Eibl G
DOI:
10.1038/s41575-020-0324-6
发表时间:
2020-08
期刊:
Nature reviews. Gastroenterology & hepatology
影响因子:
--
作者:
Eibl G
通讯作者:
Eibl G